Changchun Intellicrown Pharmaceutical Co. LTD Report issue

For profit Phase 1
Founded: Changchun China (2019)
Status: Defunct (2020)

Organization Overview

First Clinical Trial
2019
NCT04126590
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2020

Timeline

NOW
  • Now

Alternative names

Changchun Intellicrown Pharmaceutical Co. LTD

Active Ingredients

Drugs in Phase 1 Trials (2)

kn044 (1 trial)

zz06 (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Neoplasms (Phase 1)

Overview

  • Highest Phase: Phase 1
  • # of Trials: 2
  • # of Trial APIs: 2